Pharmacogenomics & Precision Psychiatry at 39th ECNP Congress

7 sessions on pharmacogenomics & precision psychiatry · October 10–13, 2026, Munich, Germany. Compare pharmacogenomics & precision psychiatry at other meetings →

Saturday, October 10

Lecture
E01 – Targeting the immune pathogenesis for the development of novel diagnostics and therapeutics of affective and non-affective psychosis
Paolo Enrico · Rachel Upthegrove
Educational update on immune-molecular patient stratification and multimodal inflammation measures in early psychosis.
Inflammation & Immunopsychiatry · Schizophrenia & Psychosis

Symposium
S04 – Updates on bipolar disorder research: advancing translation into clinical practice
Galila Agam · Olav B Smeland · Frank Bellivier · Caterina del Mar Bonnin Roig
Sex differences, genomics, lithium-response prediction (R-LiNK), and cognitive resilience in bipolar disorder.
Bipolar Disorder · Lithium & Mood Stabilizers
Symposium
S05 – Biomarker-based prediction and stratification in ADHD – where do we stand?
Cristine Marie Yde Ohki · Carmen Schiweck · Barbara Franke · Marta Ribasés
Microbiota metabolites, inflammation, epigenetics, and polygenic risk as candidate stratification biomarkers in ADHD.
ADHD · Inflammation & Immunopsychiatry
Symposium
MS02 – Proof-of-concept studies showcasing biomarker potential
Leanne Williams · Daniel Gehrlach
Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.
Depression · Drug Pipeline & Clinical Trials

Course
CS02 – ECNP Child & Adolescent Psychiatry Course Session – from evidence-based care to precision approaches
Hilgo Bruining · Gonzalo Salazar de Pablo
Interactive course on evidence-based and precision approaches to child and adolescent psychiatry and neurodevelopmental disorders.
Autism & Neurodevelopmental Disorders · Child & Adolescent

Symposium
S20 – How can artificial intelligence transform mental health research?
Eleonora Maggioni · Pavol Mikolas · Saige Rutherford · Lin Baihan
Multimodal AI for patient stratification, generative AI for symptom extraction, and algorithmic fairness in clinical neuroscience.
Digital Psychiatry & AI
Symposium
S21 – Neurobiology and clinical translation of treatment resistance in major psychiatric disorders
Michael Ziller · Esmée Verwijk · Alessandra Minelli · Koen Demyttenaere
iPSC models, pharmacogenomics, ECT cognitive effects, and lived-experience perspectives on treatment resistance.
Neuromodulation (ECT, TMS) · Neuroscience & Mechanisms · Treatment-Resistant Depression